New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Probiotic Blends Containing L. acidophilus DDS®-1 Offer Condition-Specific Results

Premium Probiotic Blends containing the super strain, Lactobacillus acidophilus DDS®-1 have demonstrated condition-specific health benefits. A recent clinical case study demonstrated the effectiveness of the probiotic blend containing L. acidophilus DDS®-1, Bifidobacterium longum, Bifidobacterium lactis and Bifidobacterium bifidum in relieving the symptoms of irritable bowel syndrome (IBS). A clinical study published last year demonstrated effectiveness of the L. acidophilus DDS®-1, B. lactis blend in reducing the symptoms of atopic dermatitis in young children.

Health Attributes
The health attributes of L. acidophilus DDS-1 have been well documented and include:

• Human isolates that adapt well to the human body
• Acid and bile resistance that make it well-suited for intestinal survival
• Ability to promote digestive health
• Creates an unfavorable environment for pathogens
• Maintains natural immune defenses
• Contributes to good balance of intestinal flora

Lactobacillus acidophilus DDS®-1 is a unique endogenous human isolate extensively researched and protected by US patent and Trademark and manufactured and marketed by UAS Laboratories, Inc. Since 1979, L. acidophilus DDS®-1 strain has been marketed worldwide as an effective probiotic strain. It has been the subject of a variety of in vitro, human and animal studies for more than 40 years. The focus of the efficacy research on this strain has been on its nutritional, antibacterial, antipathogenic, anticarcinogenic and antiallergic properties. The antibacterial substance, acidophilin, produced by L. acidophilus DDS®-1, has been demonstrated to inhibit over 26 different pathogenic strains.

An Exceptionally Stable and Effective Probiotic
Lactobacillus acidophilus DDS®-1 is available as a high count freeze-dried material taking advantage of UAS Laboratories’ latest stability innovation. This probiotic superstrain is suitable for applications in dietary supplements, food and beverages. UAS Labs innovations have made our blends room temperature stable with 7% loss of potency in one year.

Proven, Tested Blends Now Available
Four tested blends containing L. acidophilus DDS®-1 are now available:

• DDS Probiotic Blend No. 1 containing L. acidophilus DDS®-1, Bifidobacterium longum plus FOS (5 billion CFU/gram)
• DDS Probiotic Blend No. 2 containing L. acidophilus DDS®-1, B. lactis plus FOS (5 billion CFU/gram)
• DDS Probiotic Blend No. 3 containing L. acidophilus DDS®-1, B. longum, B. lactis, B. bifidum plus FOS (10 billion CFU/gram)
• DDS Probiotic Blend No. 4 containing Lactobacillus acidophilus DDS®-1 plus FOS (fructooligosaccharides) – 5 billion CFU/gram

Additionally, UAS Labs formulates custom blends containing L. acidophilus DDS®-1 and other specialty probiotic strains per customer specification. UAS Labs also provides probiotic bulk capsules and tablets per UAS and/or customer specification. The newest patent-pending, innovative Cran-Gyn DDS® blend containing DDS® probiotics, cranberry fruit extract and natural D-mannose is available to customers worldwide. DDS® probiotic blends are only available from UAS Laboratories, Inc. ([email protected])

DDS® Probiotic blends applications include: supplements, food and beverages.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.